| HOME | HELP | E-MAIL ALERTS | SEARCH |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 108 No. 4 October 2001, pp. 1033-1044
This clinical practice guideline provides
evidence-based recommendations for the treatment of children diagnosed
with attention-deficit/hyperactivity disorder (ADHD). This guideline,
the second in a set of policies on this condition, is intended for use
by clinicians working in primary care settings. The initiation of
treatment requires the accurate establishment of a diagnosis of ADHD;
the American Academy of Pediatrics (AAP) clinical practice guideline on
diagnosis of children with ADHD1 provides direction in
appropriately diagnosing this disorder.
The AAP Committee on Quality Improvement selected a subcommittee
composed of primary care and developmental-behavioral
pediatricians and other experts in the fields of neurology, psychology,
child psychiatry, education, family practice, and epidemiology. The subcommittee partnered with the Agency for Healthcare Research and
Quality and the Evidence-based Practice Center at McMaster University,
Ontario, Canada, to develop the evidence base of literature on this
topic.2 The resulting systematic review, along with other
major studies in this area, was used to formulate recommendations for
treatment of children with ADHD. The subcommittee also reviewed the
multimodal treatment study of children with ADHD3 and the
Canadian Coordinating Office for Health Technology Assessment report
(CCOHTA).4 Subcommittee decisions were made by consensus
where definitive evidence was not available. The subcommittee report
underwent extensive review by sections and committees of the AAP as
well as by numerous external organizations before approval from the AAP
Board of Directors.
The guideline contains the following recommendations for the treatment
of a child diagnosed with ADHD:
Related Articles
This article has been cited by other articles:
 |
|
 |
|
  V. L. Vetter, J. Elia, C. Erickson, S. Berger, N. Blum, K. Uzark, and C. L. Webb Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing Circulation, May 6, 2008; 117(18): 2407 - 2423. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mannuzza, R. G. Klein, N. L. Truong, J. L. Moulton III, E. R. Roizen, K. H. Howell, and F. X. Castellanos Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood Am J Psychiatry, May 1, 2008; 165(5): 604 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Davidson Literature Review: ADHD in Adults: A Review of the Literature J Atten Disord, May 1, 2008; 11(6): 628 - 641. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Heneghan, A. S. Garner, A. Storfer-Isser, K. Kortepeter, R. E. K. Stein, and S. McCue Horwitz Use of Selective Serotonin Reuptake Inhibitors by Pediatricians: Comparing Attitudes of Primary Care Pediatricians and Child and Adolescent Psychiatrists Clinical Pediatrics, March 1, 2008; 47(2): 148 - 154. [Abstract] [PDF]
|
|
|
|
|
|
A. R. Perwien, C. J. Kratochvil, D. Faries, B. Vaughan, J. Busner, K. E. Saylor, C. M. Buermeyer, S. Kaplan, and R. Swindle Emotional Expression in Children Treated With ADHD Medication: Development of a New Measure J Atten Disord, March 1, 2008; 11(5): 568 - 579. [Abstract] [PDF]
|
|
|
|
 |
|
 T. J. Power, J. A. Mautone, P. H. Manz, L. Frye, and N. J. Blum Managing Attention-Deficit/Hyperactivity Disorder in Primary Care: A Systematic Analysis of Roles and Challenges Pediatrics, January 1, 2008; 121(1): e65 - e72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. E. Arnold, R. L. Lindsay, F. A. Lopez, S. E. Jacob, J. Biederman, R. L. Findling, and Y. Ramadan Treating Attention-Deficit/Hyperactivity Disorder With a Stimulant Transdermal Patch: The Clinical Art Pediatrics, November 1, 2007; 120(5): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Lien, J. S. Carlson, S. Hunter-Oehmke, and K. A. Knapp A Pilot Investigation of Teachers' Perceptions of Psychotropic Drug Use in Schools J Atten Disord, September 1, 2007; 11(2): 172 - 177. [Abstract] [PDF]
|
|
|
|
|
|
S. V. Faraone, J. Biederman, and B. Zimmerman An Analysis of Patient Adherence to Treatment During a 1-Year, Open-label Study of OROS(R) Methylphenidate in Children With ADHD J Atten Disord, September 1, 2007; 11(2): 157 - 166. [Abstract] [PDF]
|
|
|
|
 |
|
 J. N. Epstein, D. Rabiner, D. E. Johnson, D. P. FitzGerald, A. Chrisman, A. Erkanli, K. K. Sullivan, J. S. March, P. Margolis, E. C. Norton, et al. Improving Attention-Deficit/Hyperactivity Disorder Treatment Outcomes Through Use of a Collaborative Consultation Treatment Service by Community-Based Pediatricians: A Cluster Randomized Trial Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 835 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Froehlich, B. P. Lanphear, J. N. Epstein, W. J. Barbaresi, S. K. Katusic, and R. S. Kahn Prevalence, Recognition, and Treatment of Attention-Deficit/Hyperactivity Disorder in a National Sample of US Children Arch Pediatr Adolesc Med, September 1, 2007; 161(9): 857 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Brown and J. M. Perrin Measuring Outcomes in Attention-Deficit/Hyperactivity Disorder J. Pediatr. Psychol., July 1, 2007; 32(6): 627 - 630. [Full Text] [PDF]
|
|
|
|
|
|
W. E. Pelham, E. M. Foster, and J. A. Robb The Economic Impact of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents J. Pediatr. Psychol., July 1, 2007; 32(6): 711 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Leslie and M. L. Wolraich ADHD Service Use Patterns in Youth J. Pediatr. Psychol., July 1, 2007; 32(6): 695 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Castle, R. E. Aubert, R. R. Verbrugge, M. Khalid, and R. S. Epstein Trends in Medication Treatment for ADHD J Atten Disord, May 1, 2007; 10(4): 335 - 342. [Abstract] [PDF]
|
|
|
|
|
|
J. Biederman, S. W. Ball, E. Mick, M. C. Monuteaux, R. Kaiser, E. Bristol, and S. V. Faraone Informativeness of Maternal Reports on the Diagnosis of ADHD: An Analysis of Mother and Youth Reports J Atten Disord, May 1, 2007; 10(4): 410 - 417. [Abstract] [PDF]
|
|
|
|
 |
|
 M. L Wolraich Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD Evid. Based Ment. Health, May 1, 2007; 10(2): 60 - 60. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Leitner, G. M. Doniger, R. Barak, E. S. Simon, and J. M. Hausdorff A Novel Multidomain Computerized Cognitive Assessment for Attention-Deficit Hyperactivity Disorder: Evidence for Widespread and Circumscribed Cognitive Deficits J Child Neurol, March 1, 2007; 22(3): 264 - 276. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Cash ADHD's toll: Research papers at AAP conference paint a picture of the disorder's debilitating social, educational and financial challenges AAP News, March 1, 2007; 28(3): 20 - 21. [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Scheffler, S. P. Hinshaw, S. Modrek, and P. Levine The Global Market For ADHD Medications Health Aff., March 1, 2007; 26(2): 450 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Visser, C. A. Lesesne, and R. Perou National Estimates and Factors Associated With Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder Pediatrics, February 1, 2007; 119(Supplement_1): S99 - S106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Murray and T. L. Murray Jr. The Family Pharm: An Ethical Consideration of Psychopharmacology in Couple and Family Counseling The Family Journal, January 1, 2007; 15(1): 65 - 71. [Abstract] [PDF]
|
|
|
|
|
|
M. Knight Stimulant-Drug Therapy for Attention-Deficit Disorder (With or Without Hyperactivity) and Sudden Cardiac Death Pediatrics, January 1, 2007; 119(1): 154 - 155. [Full Text] [PDF]
|
|
|
|
|
|
R. T. Brown, A. Perwien, D. E. Faries, C. J. Kratochvil, and B. S. Vaughan Atomoxetine in the Management of Children with ADHD: Effects on Quality of Life and School Functioning. Clinical Pediatrics, November 1, 2006; 45(9): 819 - 827. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. Foreman, A. Beedie, and R. Kapuge Clinic assessment for methylphenidate maintenance therapy in secondary care: are parental questionnaires useful? Psychiatr. Bull., November 1, 2006; 30(11): 406 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. N Mendhekar and H. S Duggal Methylphenidate-Induced Rabbit Syndrome Ann. Pharmacother., November 1, 2006; 40(11): 2076 - 2076. [Full Text] [PDF]
|
|
|
|
|
|
T. E. Wilens, J. B. Prince, T. J. Spencer, and J. Biederman Stimulants and Sudden Death: What Is a Physician to Do? Pediatrics, September 1, 2006; 118(3): 1215 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pierrehumbert, M. Bader, S. Thevoz, A. Kinal, and O. Halfon Hyperactivity and Attention Problems in a Swiss Sample of School-Aged Children: Effects of School Achievement, Child Gender, and Informants. J Atten Disord, August 1, 2006; 10(1): 65 - 76. [Abstract] [PDF]
|
|
|
|
|
|
D. Gilbert Treatment of Children and Adolescents With Tics and Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 690 - 700. [Abstract] [PDF]
|
|
|
|
 |
|
 D. L. Gilbert, Z. Wang, F. R. Sallee, K. R. Ridel, S. Merhar, J. Zhang, T. D. Lipps, C. White, N. Badreldin, and E. M. Wassermann Dopamine transporter genotype influences the physiological response to medication in ADHD Brain, August 1, 2006; 129(8): 2038 - 2046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-J. Zhu, J.-S. Wang, C. L. DeVane, R. L. Williard, J. L. Donovan, L. D. Middaugh, B. B. Gibson, K. S. Patrick, and J. S. Markowitz THE ROLE OF THE POLYMORPHIC EFFLUX TRANSPORTER P-GLYCOPROTEIN ON THE BRAIN ACCUMULATION OF d-METHYLPHENIDATE AND d-AMPHETAMINE Drug Metab. Dispos., July 1, 2006; 34(7): 1116 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. F. Connor, T. J. McLaughlin, M. Jeffers-Terry, W. H. O'Brien, C. J. Stille, L. M. Young, and R. C. Antonelli Targeted child psychiatric services: a new model of pediatric primary clinician--child psychiatry collaborative care. Clinical Pediatrics, June 1, 2006; 45(5): 423 - 434. [Abstract] [PDF]
|
|
|
|
|
|
L. Diller and S. Goldstein Science, ethics, and the psychosocial treatment of ADHD. J Atten Disord, May 1, 2006; 9(4): 571 - 574. [PDF]
|
|
|
|
|
|
R. L. Gorman FDA panel recommends black box warning on ADHD stimulant medications AAP News, April 1, 2006; 27(4): 16 - 16. [Full Text]
|
|
|
|
 |
|
 V. S. Bhatara, H. B. Vogt, S. Patrick, L. Doniparthi, and R. Ellis Acceptability of a Web-based Attention-deficit/Hyperactivity Disorder Scale (T-SKAMP) by Teachers: A Pilot Study J Am Board Fam Med, March 1, 2006; 19(2): 195 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Committee on Child Health Financing Scope of Health Care Benefits for Children From Birth Through Age 21 Pediatrics, March 1, 2006; 117(3): 979 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Kemner and M. J. Lage Effect of methylphenidate formulation on treatment patterns and use of emergency room services Am. J. Health Syst. Pharm., February 15, 2006; 63(4): 317 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Wilens, K. McBurnett, O. Bukstein, J. McGough, L. Greenhill, M. Lerner, M. A. Stein, C. K. Conners, J. Duby, J. Newcorn, et al. Multisite Controlled Study of OROS Methylphenidate in the Treatment of Adolescents With Attention-Deficit/Hyperactivity Disorder Arch Pediatr Adolesc Med, January 1, 2006; 160(1): 82 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Furman What Is Attention-Deficit Hyperactivity Disorder (ADHD)? J Child Neurol, December 1, 2005; 20(12): 994 - 1002. [Abstract] [PDF]
|
|
|
|
|
|
J. P. Guevara, C. Feudtner, D. Romer, T. Power, R. Eiraldi, S. Nihtianova, A. Rosales, J. Ohene-Frempong, and D. F. Schwarz Fragmented Care for Inner-City Minority Children With Attention-Deficit/Hyperactivity Disorder Pediatrics, October 1, 2005; 116(4): e512 - e517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Ruff Attention Deficit Disorder and Stimulant Use: An Epidemic of Modernity Clinical Pediatrics, September 1, 2005; 44(7): 557 - 563. [PDF]
|
|
|
|
|
|
S. B. Wigal, J. J. McGough, J. T. McCracken, J. Biederman, T. J. Spencer, K. L. Posner, T. L. Wigal, S. H. Kollins, T. M. Clark, D. A. Mays, et al. A Laboratory School Comparison of Mixed Amphetamine Salts Extended Release (Adderall XR(R)) and Atomoxetine (Strattera(R)) in School-Aged Children With Attention Deficit/Hyperactivity Disorder J Atten Disord, August 1, 2005; 9(1): 275 - 289. [Abstract] [PDF]
|
|
|
|
|
|
M. L. Wolraich, L. Bickman, E. W. Lambert, T. Simmons, and M. A. Doffing Intervening to Improve Communication Between Parents, Teachers, and Primary Care Providers of Children With ADHD or at High Risk for ADHD J Atten Disord, August 1, 2005; 9(1): 354 - 368. [Abstract] [PDF]
|
|
|
|
|
|
D. Coghill Attention-deficit hyperactivity disorder: should we believe the mass media or peer-reviewed literature? Psychiatr. Bull., August 1, 2005; 29(8): 288 - 291. [Full Text] [PDF]
|
|
|
|
|
|
J. A. Dopheide ASHP Therapeutic Position Statement on the Appropriate Use of Medications in the Treatment of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients Am. J. Health Syst. Pharm., July 15, 2005; 62(14): 1502 - 1509. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Spencer, J. H. Newcorn, C. J. Kratochvil, D. Ruff, D. Michelson, and J. Biederman Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder Pediatrics, July 1, 2005; 116(1): e74 - e80. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Wolraich, C. J. Wibbelsman, T. E. Brown, S. W. Evans, E. M. Gotlieb, J. R. Knight, E. C. Ross, H. H. Shubiner, E. H. Wender, and T. Wilens Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications Pediatrics, June 1, 2005; 115(6): 1734 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Brown, R. W. Amler, W. S. Freeman, J. M. Perrin, M. T. Stein, H. M. Feldman, K. Pierce, M. L. Wolraich, and and the Committee on Quality Improvement, Subcommi Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence Pediatrics, June 1, 2005; 115(6): e749 - e757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Huskamp, P. A. Deverka, A. M. Epstein, R. S. Epstein, K. A. McGuigan, A. C. Muriel, and R. G. Frank Impact of 3-Tier Formularies on Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Children Arch Gen Psychiatry, April 1, 2005; 62(4): 435 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Rappley Attention Deficit-Hyperactivity Disorder N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173. [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Coles, W. E. Pelham, E. M. Gnagy, L. Burrows-Maclean, G. A. Fabiano, A. Chacko, B. T. Wymbs, K. E. Tresco, K. S. Walker, and J. A. Robb A Controlled Evaluation of Behavioral Treatment With Children With ADHD Attending a Summer Treatment Program Journal of Emotional and Behavioral Disorders, January 1, 2005; 13(2): 99 - 112. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Foy and M. F. Earls A Process for Developing Community Consensus Regarding the Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder Pediatrics, January 1, 2005; 115(1): e97 - e104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Mulhern, R. B. Khan, S. Kaplan, S. Helton, R. Christensen, M. Bonner, R. Brown, X. Xiong, S. Wu, S. Gururangan, et al. Short-Term Efficacy of Methylphenidate: A Randomized, Double-Blind, Placebo-Controlled Trial Among Survivors of Childhood Cancer J. Clin. Oncol., December 1, 2004; 22(23): 4795 - 4803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Coghill Use of stimulants for attention deficit hyperactivity disorder: FOR BMJ, October 16, 2004; 329(7471): 907 - 908. [Full Text] [PDF]
|
|
|
|
|
|
H. Marcovitch Use of stimulants for attention deficit hyperactivity disorder: AGAINST BMJ, October 16, 2004; 329(7471): 908 - 909. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Szobot, C. Ketzer, M. A. Parente, J. Biederman, and L. A. Rohde The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: A randomized clinical trial J Atten Disord, October 1, 2004; 8(2): 37 - 43. [Abstract] [PDF]
|
|
|
|
|
|
I. W. Borowsky, S. Mozayeny, K. Stuenkel, and M. Ireland Effects of a Primary Care-Based Intervention on Violent Behavior and Injury in Children Pediatrics, October 1, 2004; 114(4): e392 - e399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Furman and B. W. Berman Rethinking the AAP Attention Deficit/Hyperactivity Disorder Guidelines Clinical Pediatrics, September 1, 2004; 43(7): 601 - 603. [PDF]
|
|
|
|
|
|
J. L. Rushton, K. E. Fant, and S. J. Clark Use of Practice Guidelines in the Primary Care of Children With Attention-Deficit/Hyperactivity Disorder Pediatrics, July 1, 2004; 114(1): e23 - e28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bhatara, M. Feil, K. Hoagwood, B. Vitiello, and B. Zima National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge J Atten Disord, May 1, 2004; 7(4): 217 - 226. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Swanson, S. B. Wigal, T. Wigal, E. Sonuga-Barke, L. L. Greenhill, J. Biederman, S. Kollins, A. S. Nguyen, H. H. DeCory, S. J. Hirshe Dirksen, et al. A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study) Pediatrics, March 1, 2004; 113(3): e206 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Topolski, T. C. Edwards, D. L. Patrick, P. Varley, M. E. Way, and D. P. Buesching Quality of life of adolescent males with Attention-Deficit Hyperactivity Disorder J Atten Disord, February 1, 2004; 7(3): 163 - 173. [Abstract] [PDF]
|
|
|
|
|
|
A. S. Yusin, J. M. Perrin, M. Wolraich, and M. Stein 2001 American Academy of Pediatrics Practice Parameter on Attention-Deficit/Hyperactivity Disorder Pediatrics, February 1, 2004; 113(2): 428 - 429. [Full Text] [PDF]
|
|
